Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 6:10:360.
doi: 10.3389/fimmu.2019.00360. eCollection 2019.

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

Affiliations
Review

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

Stephen J Gaudino et al. Front Immunol. .

Abstract

Innate immunity is maintained in part by antigen presenting cells (APCs) including dendritic cells, macrophages, and B cells. APCs interact with T cells to link innate and adaptive immune responses. By displaying bacterial and tumorigenic antigens on their surface via major histocompatibility complexes, APCs can directly influence the differentiation of T cells. Likewise, T cell activation, differentiation, and effector functions are modulated by APCs utilizing multiple mechanisms. The objective of this review is to describe how APCs interact with and influence the activation of T cells to maintain innate immunity during exposure to microbial infection and malignant cells. How bacteria and cancer cells take advantage of some of these interactions for their own benefit will also be discussed. While this review will cover a broad range of topics, a general focus will be held around pathogens, cancers, and interactions that typically occur within the gastrointestinal tract.

Keywords: APC; CRC; PAMP; SCFA; SFB; TLR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of innate immune interactions under homeostasis and dysbiosis. In healthy individuals, the commensal microbiota secretes products, including SCFAs such as butyrate, that act on DCs to maintain a commensal-tolerant immune system. The presence of commensal microbes has also been associated with an increased presence of Th17 cells. Also, ILCs secrete cytokines to alter T cell function to maintain homeostasis. When dysbiosis is induced by bacterial pathogens such as S. Typhimurium, microbiota composition changes and mucus secretion increases. S. Typhimurium infection occurs via transcytosis by M cells into Peyer's patches where the bacterium can travel through lymphatic vessels to the MLN. To mount an immune response, S. Typhimurium antigens such as flagellin monomers are detected by TLR5 of DCs. DCs then produce IL-23 which promotes the release of IL-17 by memory T cells. IL-17 stimulates the differentiation of naïve CD4+ T cells into Th17 cells. Likewise, TLR9 and NOD2 receptors are activated within Paneth cells to upregulate the secretion of AMPs.
Figure 2
Figure 2
CRC altered microbiota-dependent innate immune signaling facilitates tumorigenesis. The intestinal microbiota changes with the progression of CRC. For instance, increased levels of F. nucleatum have been associated with increased severity of CRC. CRC cells also display a “leaky” epithelial layer which allows for the entrance of microbial products into the tumor microenvironment. These products activate TLR signaling by DCs. IL-23 is then secreted by DCs to promote the secretion of IL-17A by Th17 cells. IL-17A, in turn, is associated with angiogenesis.

Similar articles

Cited by

References

    1. Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin. Immunol. (2010) 125:S33–40. 10.1016/j.jaci.2009.09.017 - DOI - PubMed
    1. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology. (2008) 123:326–38. 10.1111/j.1365-2567.2007.02719.x - DOI - PMC - PubMed
    1. Walker JA, McKenzie ANJ. TH2 cell development and function. Nat Rev Immunol. (2017) 18:121–33. 10.1038/nri.2017.118 - DOI - PubMed
    1. Bradley LM, Dalton DK, Croft M. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol Baltim Md 1950. (1996) 157:1350–1358. - PubMed
    1. Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol. (2018) 9:847 10.3389/fimmu.2018.00847 - DOI - PMC - PubMed

Publication types